Key result
Female donor hearts show higher mass-adjusted hs-cTnT than male hearts during the first post-transplant week.
Why the study?
Gender affects many cardiovascular functions, but differences in markers of cell death in male versus female donor myocardium were unclear.
Do markers of perioperative ischemia/reperfusion injury differ between male and female donor myocardium in patients undergoing heart transplantation?
Observational (n=81)
No
Do markers of perioperative ischemia/reperfusion injury differ between male and female donor myocardium in patients undergoing heart transplantation?
p-value: p=0.011
Female donor hearts exhibit higher levels of necrosis markers (hs-cTnT) compared to male donor hearts during perioperative ischemia/reperfusion injury in heart transplantation.
Female donor hearts showed higher adjusted hs-cTnT; leaves open whether this signals greater perioperative injury or affects outcomes.
Many functions of the cardiovascular apparatus are affected by gender. The aim of our study was find out whether markers of cell death present in the donor myocardium differ in male and female hearts. The study involved 81 patients undergoing heart transplantation from September 2010 to January 2013. Patients were divided into two groups: male allograft (n=49), and female allograft (n=32). Two types of myocardial cell death were analyzed. High-sensitive cardiac troponin T as a necrosis marker and protein bcl-2, caspase 3 and TUNEL as apoptosis markers were measured. We observed a significantly higher level of high-sensitive cardiac troponin T after correcting for predicted ventricular mass in female donors before transplantation as well as in the female allograft group after transplantation throughout the monitored period (P=0.011). There were no differences in apoptosis markers (bcl-2, caspase 3, TUNEL) between male and female hearts before transplantation. Both genders showed a significant increase of TUNEL-positive myocytes one week after transplantation without differences between the groups. Moreover, there were no differences in caspase 3 and bcl-2 expression between the two groups. Our results demonstrated the presence of necrotic and apoptotic cell death in human heart allografts. High-sensitive cardiac troponin T adjusted for predicted ventricular mass as a marker of myocardial necrosis was higher in female donors, and this gender difference was even more pronounced after transplantation.
No takes yet. Share an insight, caveat, or question.
Smetana et al. (2017) conducted an observational in End-stage heart failure undergoing heart transplantation (n=81). Female donor allograft vs. Male donor allograft was evaluated on High-sensitive cardiac troponin T (hs-cTnT) adjusted for predicted ventricular mass after transplantation (p=0.011). Female donor hearts exhibited significantly higher levels of high-sensitive cardiac troponin T adjusted for predicted ventricular mass compared to male donor hearts throughout the first week after transplantation (P=0.011).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: